» Articles » PMID: 18195094

Clonal Heterogeneity in Polycythemia Vera Patients with JAK2 Exon12 and JAK2-V617F Mutations

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2008 Jan 16
PMID 18195094
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

We studied the lineage distribution of JAK2 mutations in peripheral blood of 8 polycythemia vera (PV) patients with exon 12 mutations and in 21 PV patients with JAK2-V617F. Using a quantitative allele discrimination assay, we detected exon 12 mutations in purified granulocytes, monocytes, and platelets of 8 patients studied, but lymphoid cells showed variable involvement and the mutation was absent in T cells. Endogenous erythroid colonies grew in all patients analyzed. One patient displayed erythroid colonies homozygous for the exon 12 mutation with evidence for mitotic recombination on chromosome 9p. In some patients with exon 12 mutations or JAK2-V617F, a proportion of endogenous erythroid colonies were negative for both JAK2 mutations. One patient carried 2 independent clones: one with an exon 12 mutation and a second with JAK2-V617F. The finding of clonal heterogeneity is compatible with the hypothesis that additional clonal events are involved in the pathogenesis of PV.

Citing Articles

Ethnic sensitivity analyses of pharmacokinetics, efficacy and safety in polycythemia vera treatment with ropeginterferon alfa-2b.

Qin A, Wu D, Liao J, Xie S, Chen H, Gao Y Front Pharmacol. 2024; 15:1455979.

PMID: 39386026 PMC: 11463156. DOI: 10.3389/fphar.2024.1455979.


Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology.

Chia Y, Siti Asmaa M, Ramli M, Woon P, Johan M, Hassan R Diagnostics (Basel). 2023; 13(1).

PMID: 36611455 PMC: 9818412. DOI: 10.3390/diagnostics13010163.


Genetic Background of Polycythemia Vera.

Regimbeau M, Mary R, Hermetet F, Girodon F Genes (Basel). 2022; 13(4).

PMID: 35456443 PMC: 9027017. DOI: 10.3390/genes13040637.


Recent Advances in the Use of Molecular Analyses to Inform the Diagnosis and Prognosis of Patients with Polycythaemia Vera.

Stuckey R, Gomez-Casares M Int J Mol Sci. 2021; 22(9).

PMID: 34068690 PMC: 8126083. DOI: 10.3390/ijms22095042.


JAK2-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionality.

Rao T, Hansen N, Stetka J, Luque Paz D, Kalmer M, Hilfiker J Blood. 2021; 137(16):2139-2151.

PMID: 33667305 PMC: 8103999. DOI: 10.1182/blood.2020005563.